 |
|
|
| |
Real world outcomes from NS5a treatment failures undergoing therapy with
sofosbuvir/velpatasvir/voxilaprevir and sofosbuvir/glecaprevir/pibrentasvir
|
| |
| |
Reported by Jules Levin
EASL 2019 April 10-14 Vienna
A. BOYLE1,2, F. MARRA1,2, R. FOX1, E. PETERS1, E. THOMSON1,3, R. GUNSON4, A BRADLEY4, S.T. BARCLAY5
1 Gartnavel General Hospital, Glasgow. 2 University of Liverpool, Liverpool.
3MRC-University of Glasgow Centre for Virus Research 4 West of
Scotland Specialist Virology Centre 5 Glasgow Royal Infirmary, Glasgow. United Kingdom
|
| |
|
|
|
|
|
